Balchem Corp
NASDAQ:BCPC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Balchem Corp
Total Equity
Balchem Corp
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Balchem Corp
NASDAQ:BCPC
|
Total Equity
$1.3B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
|
|
Sherwin-Williams Co
NYSE:SHW
|
Total Equity
$4.6B
|
CAGR 3-Years
14%
|
CAGR 5-Years
5%
|
CAGR 10-Years
18%
|
|
|
Dupont De Nemours Inc
NYSE:DD
|
Total Equity
$13.9B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
Ecolab Inc
NYSE:ECL
|
Total Equity
$9.8B
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
4%
|
|
|
PPG Industries Inc
NYSE:PPG
|
Total Equity
$7.9B
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
5%
|
|
|
Albemarle Corp
NYSE:ALB
|
Total Equity
$9.5B
|
CAGR 3-Years
6%
|
CAGR 5-Years
17%
|
CAGR 10-Years
11%
|
|
Balchem Corp
Glance View
In the world of specialty chemicals, Balchem Corp. has quietly but powerfully carved a distinguished niche. Founded in 1967, this company has grown from its humble beginnings to become a major player by focusing on innovation and strategic expansion. Balchem operates through three key segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. Each segment speaks to a broader narrative of how the company intertwines science with industry needs. At the heart of its operations is the use of advanced encapsulation technology, which involves coating sensitive ingredients to enhance their stability and effectiveness. This core competency is particularly crucial in the nutrition categories, where the company's products improve the shelf life and efficacy of vitamins, minerals, and supplements. The company’s revenue model is built on providing tailored solutions that address specific challenges within various industries. In the Human Nutrition & Health sector, Balchem supplies nutrient delivery systems to some of the most well-known dietary supplement brands, essentially helping them refine product quality and meet consumer expectations for efficacy. Meanwhile, in the Animal Nutrition & Health division, Balchem develops solutions that help improve the performance and health of livestock, which is harmoniously aligned with the global push towards more sustainable agricultural practices. The Specialty Products division rounds out Balchem’s portfolio, catering to industrial markets, including oil and gas, by providing advanced chemical solutions. Through these segments, Balchem generates income by continually expanding its portfolio of patented technologies and forming long-term partnerships with clients across the globe, ensuring its growth in an ever-evolving market.
See Also
What is Balchem Corp's Total Equity?
Total Equity
1.3B
USD
Based on the financial report for Dec 31, 2025, Balchem Corp's Total Equity amounts to 1.3B USD.
What is Balchem Corp's Total Equity growth rate?
Total Equity CAGR 10Y
10%
Over the last year, the Total Equity growth was 9%. The average annual Total Equity growth rates for Balchem Corp have been 10% over the past three years , 9% over the past five years , and 10% over the past ten years .